Phase 4 Restless Legs Syndrome Trial, By Invitation (NCT02670161)

Phase 4 Restless Legs Syndrome Trial, By Invitation NCT02670161 Sponsor: Endeavor Health Condition: Restless Legs Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT02670161 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Restless Legs Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with one of the following conditions: a brain tumor, epilepsy, migraine, mild cognitive impairment (including concussion), mild traumatic brain injury, multiple sclerosis, neuropathy, Parkinson's disease, restless legs syndrome, or stroke.
You are able to receive one of the three treatments being compared in this trial, either because it is officially approved for your condition or because it is considered a standard treatment option for your situation (confirm with trial site).

Who may not be able to join:

There are no listed exclusion criteria for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02670161

Sponsor: Endeavor Health

Phase: Phase 4

Status: By Invitation

Condition: Restless Legs Syndrome

More information: https://clinicaltrials.gov/study/NCT02670161

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with one of the following conditions: a brain tumor, epilepsy, migraine, mild cognitive impairment (including concussion), mild traumatic brain injury, multiple sclerosis, neuropathy, Parkinson's disease, restless legs syndrome, or stroke.
You are able to receive one of the three treatments being compared in this trial, either because it is officially approved for your condition or because it is considered a standard treatment option for your situation (confirm with trial site).

Who may not be able to join:

There are no listed exclusion criteria for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

By Invitation

Phase

Phase 4

Sponsor

Endeavor Health

Registry

ClinicalTrials.gov

Start date

1 May 2016

Est. completion

1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

survival free of discontinuation or alternative prevention drug (migraine trial); survival free of disability measured by FAQ score 9+ (memory trial); survival free of discontinuation or alternative anti epileptic drug (epilepsy trial)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov